Assay and Drug Development Technologies

Papers
(The H4-Index of Assay and Drug Development Technologies is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Computational Drug Repurposing Approach to Identify Potential Fatty Acid-Binding Protein-4 Inhibitors to Develop Novel Antiobesity Therapy27
Optimization and Development of Methotrexate- and Resveratrol-Loaded Nanoemulsion Formulation Using Box–Behnken Design for Rheumatoid Arthritis21
A Fully Integrated Assay Panel for Early Drug Metabolism and Pharmacokinetics Profiling21
Computational Design and Biological Depiction of Novel Naproxen Derivative19
COVID-19 and the Drug Repurposing Tsunami18
Microneedle Technology: An Insight into Recent Advancements and Future Trends in Drug and Vaccine Delivery18
Quercetin Inhibits Proliferation and Induces Apoptosis of B16 Melanoma CellsIn Vitro17
Combination of Resveratrol and Quercetin Causes Cell Growth Inhibition, DNA Damage, Cell Cycle Arrest, and Apoptosis in Oral Cancer Cells17
Antifungal Activity of Capric Acid, Nystatin, and Fluconazole and Their In Vitro Interactions Against Candida Isolates from Neonatal Oral Thrush16
Pharmacokinetics and Pharmacodynamics of Curcumin-Loaded Solid Lipid Nanoparticles in the Management of Streptozotocin-Induced Diabetes Mellitus: Application of Central Composite Design15
High-Performance Liquid Chromatography and Liquid Chromatography/Mass Spectrometry Studies on Stress Degradation Behavior of Sulfapyridine and Development of a Validated, Specific, Stability-Indicatin12
Albumin-Coated Mesoporous Silica Nanoparticles of Docetaxel: Preparation, Characterization, and Pharmacokinetic Evaluation11
0.066199064254761